Verrica's Phase III Success Paves Way For Filing Of New Cantharidin Formulation VP-102

 
• By Emily Hayes
  
Arrow flying to target with radial motion blur
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D